As a new type of foreign trade service provider driven by technological transformation and export business, HiSiaddi has built a "1+2+3+4=1" service system and can supply graviola extract sourced from multiple well-known original manufacturers. A foreign trader with R&D capabilities, HiSiaddi has repeatedly conducted multi-round factory inspections of graviola extract manufacturers and acquired in-depth objective insights into various brands. It regularly analyzes graviola extract manufacturers for clients to match suitable products. Below is a brand selection recommendation case.
If you require further comparative analysis of brands and product models, please contact HiSiaddi customer service.
The purchaser is VitaSana GmbH, based in Munich, Germany, a mid-to-high-end local functional dietary enterprise whose products are sold in premium German organic supermarkets, chain rehabilitation pharmacies and private wellness clinics in Switzerland. Its two core product lines are graviola soft capsules and oral liquids. Raw materials must meet EU EC 396 226-pesticide-residue standards, German LFGB food regulations, USP Pharmacopeia and cGMP production specifications. Annual planned procurement volume of graviola extract: 14.2 tons, split into two raw material grades: high-acetogenin powder for capsules and cold-water instant modified powder for oral liquids.
First-time sourcing in China, the client had no familiarity with brand segmentation, product models and process advantages of domestic plant extract manufacturers. It contacted five top factories: Guangdong Kangyuan Bio, Hainan Nanfan Bio, Xi’an Sinuote, Yulin Herbal Extract and Shaanxi Xintianyu. Each manufacturer only promoted its own products and refused neutral commentary on peer strengths, with no horizontal cross-brand parameter comparison available. The client received five samples with inconsistent parameters and large price gaps, unable to distinguish product suitability. Sample testing by German third-party laboratories revealed issues including unstable active content and poor water solubility, halting product selection for 38 days. The client entrusted HiSiaddi to conduct neutral brand evaluation, cross-product technical decomposition and screening of matching brands and models.
Drawing on plant extraction technology, raw material traceability and overseas regulatory expertise, HiSiaddi completed on-site verification of factory production lines, testing laboratories and raw material supply chains, delivering objective breakdowns of technology, flagship models, strengths and weaknesses for all five brands without bias toward any single manufacturer:
Core strengths: Exclusive domestic GMP production line combining supercritical CO₂ and low-temperature ethanol dual extraction; long-term supplier to By-health and Guangzhou Pharmaceutical Holdings; stable import channels for Ecuadorian fresh fruits with industry-leading stability in annonaceous acetogenin internal control. Three mainstream models:
1. KY-52 pharmaceutical concentrated powder: 5.2%±0.2% total acetogenins, vacuum-dried dry powder optimized for soft capsule filling;
2. KY-S01 water-soluble modified powder: no dextrin additives, low-temperature cyclodextrin inclusion with no precipitation after refrigeration at 4°C, dedicated to oral liquids;
3. KY-P10 conventional ratio extract (10:1): water-extracted crude powder only suitable for low-priced solid beverages, incompatible with the client’s high-end formulations. Weaknesses: Premium pricing for modified water-soluble powder; 7–10 day lead time for small-batch sampling.
Core strengths: Backed by Hainan Nanfan Breeding Base with an in-house laboratory for annonaceous acetogenin monomer purification; patented Arnoldine purification process; strict internal pesticide residue control aligned with EU standards. Mainstream models:
1. NF-51 high-purity acetogenin powder: 5.1% total acetogenins, multi-stage resin refining with ultra-low impurities for premium clinic-grade soft capsules;
2. NF-L leaf extract (10:1): leaf-extracted powder with high polyphenol content primarily for tea raw materials. Weaknesses: No water-soluble modification production line for mass production of oral liquid instant powder; limited fresh fruit production capacity with tight scheduling for large orders.
Core strengths: Wholly-owned subsidiary of Yulin Pharmaceutical; drafted national testing standards for graviola polyphenols with Chinese medicinal herb-grade strict heavy metal control systems. Mainstream model: YL-48 conventional concentrated powder with acetogenin content ranging from 4.7% to 5.0%, offering cost-effectiveness. Raw materials mainly sourced from domestically cultivated sugar apple fruits. Weaknesses: No stable supply channel for imported Ecuadorian fresh fruits; maximum acetogenin content fails to hit the client’s mandatory 5.2% threshold, incompatible with high-end formulation requirements.
Core strengths: Large mass production capacity with abundant off-the-shelf conventional ratio extracts and fast small-batch sample delivery. Mainstream models: SN-10 (10:1 water extract powder), SN-20 (20:1 ethanol extract powder). Weaknesses: Focus on economical ratio extracts with no customized low-temperature refining production lines, unable to stably lock 5.2% acetogenin content; high powder impurity levels failing EU high-end dietary market access standards.
Strengths: Low quotation and abundant off-the-shelf inventory; flagship model XT-30 ratio extract powder. Weaknesses: Raw materials mixed with domestically cultivated fruits leading to severe content fluctuations; no full third-party pesticide residue test reports, only suitable for low-grade feed and cheap solid beverages.
Common industry pain point: All manufacturers only promote their own advantages and will not voluntarily disclose competitors’ strengths in water-soluble modification, imported fruit raw materials and acetogenin stability. Independent client screening easily results in misselection guided by single manufacturer sales teams.
Combining the client’s dual-formulation requirements (capsules + oral liquids), mandatory total acetogenin ≥5.2%, Ecuadorian fruit feedstock and full EU compliance standards, three manufacturers (Yulin Herbal Extract, Sinuote, Xintianyu) were eliminated for failing parameter or raw material requirements. Two mid-to-high-end brands were finalized with three matching models selected:
1. Kangyuan KY-52 (core raw material for soft capsules): 5.2%±0.2% total acetogenins, co-extracted from whole Ecuadorian fruits via dual low-temperature extraction processes with excellent powder fluidity eliminating filling blockages for the client’s mass capsule production line;
2. Kangyuan KY-S01 (core raw material for oral liquids): Filler-free modified water-soluble powder fully soluble in cold water with no precipitation during long-term low-temperature storage, perfectly matching the client’s oral liquid formula;
3. Nanfan NF-51 (alternative raw material for premium clinic soft capsules): 5.1% acetogenins with ultra-deep impurity removal and impurity levels superior to national standards, dedicated to the client’s premium clinic-exclusive capsule product line for tiered product portfolio layout.
HiSiaddi coordinated unified sample delivery of the three models from both manufacturers and assisted with sample testing at German SGS laboratories per full EC 396 and LFGB EU standards, all passing compliance screening. Pilot production trials conducted in the client’s German GMP workshop delivered consistent performance: KY-52 achieved capsule fill weight error within ±2%, KY-S01 remained clear without precipitation after 90 days of refrigeration for oral liquids, and NF-51 matched premium clinic formulation requirements. The client ultimately signed an annual framework order of 14.2 tons: 12.4 tons combined Kangyuan KY-52 (7.6 tons) + KY-S01 (4.8 tons), plus 1.8 tons of reserve Nanfan NF-51, scheduled for monthly production across 10 batches throughout the year.
Mid-to-high-end European brands lack familiarity with tiered domestic plant extract manufacturers, and manufacturer sales teams adopt self-serving strategies focused solely on promoting internal products. Independent sourcing without neutral third-party cross-brand comparison easily leads to misselection. Leveraging a multi-brand database and process expertise, HiSiaddi delivers objective cross-manufacturer strength and weakness analysis, matching models in reverse alignment with the client’s end-product formulations to avoid raw material selection risks while supporting tiered high/mid-end product raw material layout for the client. Subsequent new demand for high-end EU skincare-grade graviola extract procurement continued to entrust HiSiaddi with brand screening services.
If you require further comparative analysis of brands and product models, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
